New! Sign up for our email newsletter on Substack.

An Early Study of a New Treatment (Tocilizumab) for Lupus

Interleukin-6 (IL-6) is a protein that helps to control inflammation in the body. Lupus patients sometimes have increased IL-6 in the blood, and some studies suggest that IL-6 might go up with lupus flares. If the activity of IL-6 could be blocked, it might help to decrease inflammation.

What did the researchers learn?


Quick Note Before You Read On.

ScienceBlog.com has no paywalls, no sponsored content, and no agenda beyond getting the science right. Every story here is written to inform, not to impress an advertiser or push a point of view.

Good science journalism takes time — reading the papers, checking the claims, finding researchers who can put findings in context. We do that work because we think it matters.

If you find this site useful, consider supporting it with a donation. Even a few dollars a month helps keep the coverage independent and free for everyone.


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.